ETFIQ
RankingsCompareHoldingsResearch
My portfolioWeekly note

HRTS · Tema Heart & Health ETF

Equity fundActively managed0.75% fee$53mSince Nov 21, 2023Fund page at the issuer ↗SEC filings ↗
Share on XDownload as PDFCompareAdd to portfolioAlerts

HRTS is actively managed and returned +13.8% over the past year.

+13.8%
Total return, 1 year
0.75%
Expense ratio
45
Holdings
−7.9%
Below its high
WindowTotal returnS&P 500Gap to S&P 500Gap to Nasdaq-100
3M Jul 2 – Oct 2, 2026−3.9%+3.6%−7.5 pts−9.2 pts
6M Apr 2 – Oct 2, 2026+6.3%+17.9%−11.6 pts−22.1 pts
1Y Oct 2, 2025 – Oct 2, 2026+13.8%+16.2%−2.4 pts−10.5 pts
Since listing Nov 21, 2023 – Oct 2, 2026+38.3%+76.1%−37.8 pts−57.9 pts

HRTS over each window to Oct 2, 2026. Every figure is an ETFIQ calculation. Source: ETFIQ.

HRTS top ten by weight, 48.2% of its 45 equity positions, from the holdings published by its issuer for Oct 2, 2026. An index fund holds what the index holds, so this is the index. Source: the issuer’s own daily file.

ELI LILLY & CO LLY 11.53%
THERMO FISHER SCIENTIFIC INC TMO 5.71%
UNITEDHEALTH GROUP INC UNH 4.79%
MERCK & CO INC MRK 4.42%
REVOLUTION MEDICINES INC RVMD 3.89%
ROCHE HOLDING AG RHHBY 3.85%
NOVO NORDISK A/S NOVOB 3.75%
JOHNSON & JOHNSON JNJ 3.61%
CYTOKINETICS INC CYTK 3.42%
GILEAD SCIENCES INC GILD 3.24%
Holdings, the issuer’s own daily file ↗
Head to head
Funds near this one
ACWIACWXAIRRAORAVDVAVEM

In plain words

HRTS is actively managed and tracks no index. Over the year to Oct 2, 2026 it returned +13.8% with distributions reinvested, against +16.2% for the S&P 500 and +24.3% for the Nasdaq-100. The prospectus expense ratio is 0.75% a year. By its holdings published by its issuer for Oct 2, 2026, 60% of the fund by weight is stocks the S&P 500 also holds, across 45 positions, with the top ten at 48.2%. It sat 7.9% below its high of Aug 19, 2026 on Oct 2, 2026.
What it tracksNo index, actively managed
Fund typeEquity fund
Category (ETFIQ)Stocks · Health care
Expense ratio (485BPOS XBRL, Jun 29, 2026)0.75%
Price$35.80
Listed sinceNov 21, 2023
Net assets (issuer page, as of Oct 2, 2026)$53m
Below its high (ETFIQ)−7.9%
Holdings45
Top ten weight48.2%
Holdings published for (the issuer’s daily file)Oct 2, 2026
Already in the S&P 500, by weight (ETFIQ)59.6%
Active share vs the S&P 500 (ETFIQ)93.3%
Already in the Nasdaq-100, by weight (ETFIQ)15.1%
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

Questions people ask about HRTS

How has HRTS performed?
Over the year to Oct 2, 2026, HRTS returned +13.8% with distributions reinvested, against +16.2% for the S&P 500. Over three years the figure is not published.
What does HRTS cost?
The prospectus expense ratio is 0.75% a year.
What does HRTS hold?
45 positions as published by its issuer for Oct 2, 2026, with the top ten at 48.2% of the fund. 60% of its weight is in stocks the S&P 500 also holds.
How far is HRTS below its high?
7.9% below its high of Aug 19, 2026, measured on the reinvested series to Oct 2, 2026.
Sources and dates
Prices, HRTS and S&P 500Tiingo end-of-day · Oct 2, 2026
Fee, 0.75%Prospectus filing with the expense ratio (SEC) ↗
Net assets, $53mIssuer page · Oct 2, 2026
HoldingsHoldings, the issuer’s own daily file · Oct 2, 2026 ↗
IssuerTema page for HRTS ↗
All fund filingsFund filings on SEC EDGAR ↗
SourceTema’s own site ↗

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

ETFIQ covers core, leveraged and inverse, buffer, thematic, option-income, alternatives and spot crypto ETFs. This fund is here because the other funds here are measured against it and portfolios hold it. ETFIQ is an independent publisher and makes no recommendations. Standards and sources

How these figures are computed →Standards and sources →Open data →
Cite this page

ETFIQ, HRTS, core fund, data as of Oct 2, 2026. https://etfiq.com/funds/hrts

Free to use with attribution; the underlying files are at Open data.

Tema: every fund ETFIQ covers→